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The poxvirus virion contains an inner tubular nucleocapsid structure. The nucleocapsid is apparently
labile to conventional electron microscopy ﬁxation procedures and has therefore been largely ignored
for decades. Advancements in electron microscopy sample preparation, notably high pressure freezing,
better preserve the nucleocapsid structure. Using high pressure freezing and electron microscopy,
we have compared the virion structures of wt virus and mutant viruses known to be deﬁcient in
packaging of viral transcription enzymes. We show that the mutant viruses lack a deﬁned nucleocapsid.
These results support the hypothesis that the nucleocapsid contains the viral DNA genome complexed
with viral transcription enzymes and structural proteins. The studies open the door to further
investigation of the composition and ultrastructure of the poxvirus nucleocapsid.
& 2012 Elsevier Inc. All rights reserved.Introduction
Poxviruses possess a large double stranded DNA genome and
replicate in the cytoplasm of infected cells. Vaccinia virus, the
virus used as a live vaccine in the eradication of smallpox, is the
laboratory prototype for the study of poxviruses (Moss, 2007).
Virions of viruses in the family Poxviridae are structurally both
unique and complex (Fig. 1) (Condit et al., 2006). The vaccinia
virion is a brick shaped particle with dimensions of approxi-
mately 360270250 nm. The particle is surrounded by a lipid
bilayer that is fabricated within cytoplasmic viral factories during
virus assembly. The viral membrane encloses the virion core
particle which itself is a brick shaped, double walled structure
with indentations on both of the largest surfaces, giving the core a
biconcave appearance in some cross sections. The space deﬁned
by the concavities in the core, between the outer surface of the
core and the inner surface of the surrounding membrane, is ﬁlled
with an apparently amorphous aggregate of proteins called lateral
bodies. The vaccinia virion contains over 70 virus coded proteins.
Of these, approximately 20 are membrane proteins and the
remainder are contained within the core or lateral bodies. Among
the core and lateral body proteins, approximately 20 are struc-
tural proteins and the remaining 30 have roles in viral early
mRNA synthesis as described below. Little is known about the
speciﬁc localization of virion proteins within the core.ll rights reserved.
.Because poxviruses must complete infection in the cytoplasm
using a DNA genome, viral transcription is self contained (Broyles,
2003). Thus vaccinia encodes and packages in the virion core not
only the viral DNA genome but also a full complement of viral
transcription and mRNA modiﬁcation enzymes, including but not
limited to a multisubunit RNA polymerase, a heterodimeric early
transcription initiation factor, a heterodimeric mRNA capping
enzyme and a heterodimeric poly(A) polymerase. Viral entry into
cells involves fusion of the viral membrane with the plasma
membrane of the cell or with a vesicle membrane following
endocytosis of infecting particles, thus releasing naked viral cores
into the cytoplasm (Moss, 2006). The enzymes within the cores
then synthesize, cap and polyadenylate early virus messenger
RNA for translation on cellular ribosomes. Early gene products
include intermediate gene transcription factors and enzymes for
DNA replication; intermediate genes encode late gene transcrip-
tion factors; late genes encode structural proteins plus the
transcription apparatus to be packaged into virions for the
subsequent round of infection.
A speciﬁc mechanism for targeted packaging of viral RNA
polymerase into virions has been proposed (Zhang et al., 1994).
Two structurally and functionally distinct species of the vaccinia
virus RNA polymerase are expressed during viral infection, one
speciﬁc for transcription of early virus genes and one speciﬁc
for intermediate and late virus genes (Ahn et al., 1994; Wright
and Coroneos, 1995). The two forms of RNA polymerase share
a common core of eight subunits. The early gene-speciﬁc form
of the RNA polymerase contains one additional subunit, H4
(aka rap94), that confers early promoter speciﬁcity to the RNA
Fig. 1. A model for vaccinia virion structure. (A) The intact MV. No attempt has
been made to represent surface tubule elements. (B) The virion core. (C) Cutaway
view. The membrane (brown/tan) has been removed from the upper half of the
virion, the near end has been removed, and the core wall (yellow/green) has been
rendered transparent, thus revealing the multiple layers, the concavities in the
core, the lateral bodies (red), and the nucleocapsid (white). (D)–(F) Sections
through the virion in three mutually perpendicular planes. A dynamic 3D model is
available on line at www.vacciniamodel.com. From Condit et al. (2006) with
permission.
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promoter-binding transcription initiation factor, VETF (Yang and
Moss, 2009). Zhang et al. (1994) previously demonstrated that
when infections are done under conditions where expression of
H4 is repressed, virions are made that contain a normal comple-
ment of viral DNA and VETF but that are defective in transcription
and contain reduced amounts of RNA polymerase and several
additional transcription enzymes. Based on these ﬁndings, Zhang
et al. (1994) proposed that a viral RNA polymerase holoenzyme
complex is targeted for packaging into virions via the H4-VETF
interaction.
The early work of Peters and Mueller, (1963) described a tube-
like structure in the innermost regions of the virion core. In
vaccinia virions this tube-like structure is approximately 250 nm
in length and 50 nm in diameter, and is folded twice upon itself
into three continuous segments. Peters noted that this structure
‘‘is the most difﬁcult to demonstrate, presumably because it is
labile under the preparatory techniques used’’ (Peters and
Mueller, 1963). Thus this structure has been largely neglected
or ignored for the past 50 years. However, recent technical
advances in electron microscopy offer an opportunity to re-
examine this tube-like structure. In particular high pressure
freezing (Sosinsky et al., 2008) as a method of sample preparation
seems to preserve signiﬁcant detail of virion substructure, includ-
ing remarkable images of the tube-like structure (Heuser, 2005).
We hypothesize that the internal tube-like structure in vacci-
nia virions contains viral DNA and transcription enzymes, perhaps
bound by additional structural proteins. Thus this structure ﬁts
the deﬁnition of a viral nucleocapsid and henceforth we will use
the term nucleocapsid to refer to the tube-like structure. If the
nucleocapsid does indeed contain viral transcription enzymes,
then virions which are assembled in the absence of H4 and are
thus deﬁcient transcription enzymes might be expected to con-
tain an aberrant nucleocapsid, or lack a deﬁned nucleocapsid
structure altogether. In this paper we investigate the impact of H4
mutants on nucleocapsid structure.Results
Mutant viruses
Our goal was to examine the nucleocapsid structure of virions
that lacked the full complement of transcription enzymes. To this
end we obtained from Moss and co-workers an IPTG inducible
mutant in the vaccinia H4L gene, called here vH4i. vH4i was
engineered by Zhang et al. (1994) to contain a lac operator
positioned between the H4L gene promoter and coding sequence,
and a constitutively expressed lac repressor gene inserted into the
non-essential viral thymidine kinase gene. Thus H4L gene tran-
scription in vH4i is activated in the presence of the lac operon
inducer IPTG and repressed in the absence of IPTG. Suspecting
that H4 might be required in low or catalytic amounts during
infection, Zhang et al. (1994) also mutated the H4L gene promoter
in vH4i to reduce the basal level of expression, even though this
mutation prevented full H4 expression in the presence of IPTG.
The resulting mutant virus had an intermediate phenotype both
in the presence and absence of inducer. In a plaque assay the vH4i
formed smaller than wild type sized plaques in the presence of
inducer and ‘‘tiny’’ plaques in the absence of inducer. In a one step
growth experiment the virus demonstrated low level but readily
detectable growth in the absence of inducer, and growth in the
presence of inducer that was signiﬁcantly enhanced compared to
growth in the absence of inducer but nevertheless less than wild
type growth. Despite the intermediate nature of the phenotype,
the induction and repression of H4 synthesis was sufﬁcient to
allow for growth of virus stocks in the presence of inducer for use
in experiments, and demonstration of a clear phenotype during
infections done in the absence of inducer. Our own experience
with vH4i reproduces this phenotype (data not shown).
We also screened our own collection of temperature sensitive
mutants to identify ts alleles of H4 that might be useful in probing
nucleocapsid structure. Our laboratory and others have previously
identiﬁed ﬁve ts alleles in the H4 gene, four in the strain WR
background (Cts1, Cts31, Cts55, Cts58) and one in the IHDW
background (Dts78) (Condit and Motyczka, 1981; Condit et al.,
1983; Thompson and Condit, 1986; Kane and Shuman, 1992;
Lackner et al., 2003; Kato et al., 2008). Among these mutants we
sought one which might be restricted for growth at 37 1C rather
than the usual non-permissive temperature of 39.7 1C, so that
high temperature effects that sometimes complicate interpreta-
tion of results with ts mutants could be avoided. A screen of all
ﬁve ts alleles revealed that Cts1 was ts for plaque formation at
both 37 1C and 39.7 1C (not shown). The temperature proﬁle of
Cts1 replication was conﬁrmed in a one step growth experiment,
demonstrating little or no replication of Cts1 at 37 1C (Fig. 2).
Therefore Cts1 was chosen for further study. Previous studies
have demonstrated that under non-permissive conditions, Cts1
infections display a pattern of gene expression that is indistin-
guishable from wt infections (Condit and Motyczka, 1981; Condit
et al., 1983; Kane and Shuman, 1992). The same studies showed
that Cts1 infections done under non-permissive conditions pro-
duced virions that were indistinguishable from wt virions, how-
ever nucleocapsid structure was not speciﬁcally investigated in
these studies (Kane and Shuman, 1992).
Chemical composition and biological activity of puriﬁed mutant
virions
In order to evaluate the chemical composition and biological
activity of mutant virions, we infected monolayers of BSC40 cells
with mutant virus at moi¼5 under permissive (31 1C for Cts1 and
þ IPTG for vH4i) or non-permissive (37 1C for Cts1 and  IPTG for
vH4i) conditions, and when complete CPE was observed, we
Table 1
Speciﬁc infectivity of mutant viruses produced under permissive and non-permissive
conditionsa.
Virus Particles/cellb Particles/PFU
wt, 31 1C 767 (756, 778) 31
wt, 37 1C 787 (787) 28
Cts1, 31 1C 652 (828, 725, 403) 18
Cts1, 37 1C 685 (720, 650) 789
vH4i, þ IPTG 1075 (864, 1286) 74
vH4i,  IPTG 906 (876, 936) 218
a Virus was grown and puriﬁed as described in the Materials and methods
section and in the legend to Fig. 3. Yields were calculated based on light scattering
measured at 260 nm and titers were determined by plaque titration under
permissive conditions.
b Averages of 2–3 preparations are shown with results from individual
preparations in parentheses. The value for wt, 37 1C was from a single experiment.
MWwt 1-31 1-37 H4+ H4-
50
15
75
37
25
150
Fig. 3. SDS gel electrophoresis of puriﬁed wt and mutant virions. Mutant virus
was grown from moi¼5 infections under permissive (31 1C for Cts1 and þ IPTG for
vH4i) or non-permissive (37 1C for Cts1 and  IPTG for vH4i) conditions and
puriﬁed by sucrose gradient sedimentation as described in the Materials and
methods section. 15 mg of virus was loaded in each lane and the gel was stained
with Coomassie blue following electrophoresis. MW¼molecular weight markers,
with molecular weights indicated in kD. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 2. One step growth characteristics of Cts1. Conﬂuent monolayers of BSC40 cells were infected at moi¼10 with either wt or Cts1 and incubated for various times at
various temperatures as indicated. Yields were determined by plaque titration at 31 1C.
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fugation (Materials and methods section). Virus yields were
determined by measuring light scattering following virus puriﬁ-
cation, and infectivity was determined by plaque assay (Table 1).
When grown under permissive or non permissive conditions
following a high multiplicity infection, wt virus, Cts1 and vH4i
produced similar quantities of virions, between 650 and 1000
particles per cell. The speciﬁc infectivity of wt virions produced at
31 1C or 37 1C and Cts1 produced at 31 1C were similar, between
20 and 30 particles/pfu. On average, the speciﬁc infectivity of
vH4i grown in the presence of IPTG was approximately two fold
lower than wt or Cts1 viruses grown under permissive conditions.
The speciﬁc infectivity of vH4i virions grown under non-
permissive conditions was reduced approximately three fold
compared to vH4i infections done under permissive conditions,
and the speciﬁc infectivity of Cts1 grown under non-permissive
conditions was decreased approximately 25–40 fold compared to
wt or Cts1 virions grown under permissive conditions. Thus,
mutant virus infections produce similar numbers of virus parti-
cles regardless of infection conditions, however virions produced
during both Cts1 and vH4i infections done under non-permissive
conditions were reduced in infectivity.
The protein composition of puriﬁed mutant virions was
evaluated by SDS gel electrophoresis followed by Coomassie
staining. No signiﬁcant differences were observed in the compo-
sition of the most abundant proteins when comparing wt virions
or mutant virions produced under permissive or non-permissive
conditions (Fig. 3). Close inspection of the gel shown in Fig. 3
reveals a faint doublet migrating with an apparent MW of 150 kD
in the lanes loaded with wt virus and Cts1 virus grown at 31 1C,
but not in the other lanes. This doublet likely represents the two
largest subunits of the viral RNA polymerase and suggests thatthis enzyme is present in reduced quantities in Cts1 virions
puriﬁed from infections done at 37 1C, or from vH4i virions
puriﬁed from infections done either in the presence or absence
of IPTG.
The DNA composition of wt and mutant virions was compared
by dot blot analysis. Varying quantities of puriﬁed virions were
adsorbed to nitrocellulose ﬁlters and the DNA detected by
hybridization. This experiment was repeated on three different
occasions using both technical and biological replicates within
experiments. Results from a representative experiment are shown
in Fig. 4. We observed that all of the virus preparations contain
viral DNA, and no consistent variation in amount of DNA was
observed when comparing virus preparations. We conclude that
wild type and mutant virions contain similar amounts of DNA
regardless of whether they were produced under permissive or
non-permissive conditions.
Puriﬁed wt and mutant virion cores were compared for their
ability to catalyze early viral transcription in vitro. Virus was
permeabilized with NP40 and incorporation of radiolabeled
nucleoside triphosphate into acid insoluble material was mea-
sured with respect to time of incubation (Fig. 5). Whether grown
at 31 1C or 37 1C, wt virion cores were signiﬁcantly more active
in transcription than any of the mutant virus preparations.
Cts1 virions grown at 37 1C were inactive in transcription. Cts1
virions grown at 31 1C were slightly more active in transcription
Fig. 4. Assay for DNA in mutant virions. Dilutions of virus were adsorbed to
nitrocellulose ﬁlters, the ﬁlters were processed for hybridization to 32P labeled
vaccinia virus DNA and the hybridization quantiﬁed using a phorhporimager.
(A) Image. (B) Quantiﬁcation.
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Fig. 5. Assay of mutant virions for core transcription. Virus was incubated in the
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tion of radioactivity into acid insoluble material was measured with respect to
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Fig. 6. Immunoblot analysis of wt and mutant virions. Puriﬁed wt or mutant
virions grown under conditions indicated at the top of the ﬁgure were analyzed by
immunoblot analysis using antibodies speciﬁc to the virion proteins indicated at
the left of each row. Immunoblots were developed using chemiluminescence as
described in the Materials and methods section. The relevant portions of each
immunoblot are shown. The assay for H4 did not include wt virions grown at
31 1C, and the assay for E1 did not include wt virions grown at 37 1C. In the E1
immunoblot the wt 31 and Cts1 31 lanes were originally directly adjacent to each
other; these two lanes were separated for the ﬁgure to maintain the overall
alignment of the columns. The E4L gene produces two proteins comprising the
fastest and slowest migrating bands in the immunoblot. The identity of the middle
band is unknown.
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transcription whether they were grown under permissive or
non-permissive conditions. In general, the results demonstrate
that the mutant virions were defective in transcription, and that
the degree of the defect was dependent upon the growth condi-
tions for Cts1 virions.
We used western blot analysis to estimate amounts of several
individual proteins contained in puriﬁed virions (Fig. 6). In
addition to the mutant protein itself, H4 (rap94), the proteins
assayed included: three viral RNA polymerase subunits, J6
(rpo147), A24 (rpo132), E4 (rpo30); both the large and the small
subunits of the heterodimeric viral mRNA capping enzyme, D1
(cap L) and D12 (cap S), respectively; the early gene transcription
termination-critical nucleoside phosphohydrolase, D11 (NPH I);both the large and the small subunits of the heterodimeric viral
poly(A) polymerase, E1 (pap L) and J3 (pap S), respectively; a
virion-encapsidated single stranded DNA binding protein, I3 (DNA
bp); and two core proteins, E8 (core) and A10 (4a). The mutant
gene product, H4 (rap94), was present in reduced amounts in
all the mutant virion preparations compared to wild type virions.
Among the mutant virion preparations, H4 was most abundant
in Cts1 virions grown at 31 1C and vH4i virions grown in the
presence of IPTG. The difference in H4 content comparing mutant
virions grown under permissive and non-permissive conditions
was more pronounced in Cts1 compared to vH4i. Several proteins
were found to be present in reduced amounts in Cts1 virions
grown at 37 1C, or in vH4i virions grown in either the presence or
absence of IPTG. These proteins include J6 (rpo147), A24 (rpo132),
E4 (rpo30), D1 (cap L), D12 (cap S), D11 (NPH I), and E1 (pap L).
Several proteins were found to be present in wt or mutant virions
in equivalent amounts regardless of the conditions under which
the virus was grown. These included J3 (pap S), I3 (DNA bp),
E8 (core) and A10 (4a). In summary, consistent with previous
results obtained with vH4i (Zhang et al., 1994), H4 mutant virions
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consistent with previous observations, the deﬁciencies observed
in vH4i virions occur independently of growth conditions.
The deﬁciencies in Cts1 virions are speciﬁc to growth under
non-permissive conditions.
To verify that proteins that were deﬁcient in mutant virions
were actually synthesized in normal amounts during infection,
synthesis of selected proteins was assessed by immunoblot
analysis of infected cell lysates (Fig. 7). The results show that
the mutant protein H4 (rap94) itself and one other RNACts1wt
31°C 37°C 31°C 37°C
0 3 6 9 12 3 6 9 12 0 3 6 9 12 3 6 9 12
H4 (rap94)
A24 (rpo132)
Fig. 7. Immunoblot analysis of virion protein synthesis in infected cells. Mono-
layers of BSC40 cells were infected with wt virus or Cts1 at moi¼10 and incubated
for the various times and temperatures indicated at the top of the ﬁgure. Infected
cell extracts were analyzed by immunoblot analysis using antibodies speciﬁc to
the virion proteins indicated at the left of each row. Immunoblots were developed
using chemiluminescence as described in the Materials and methods section.
The relevant portions of each immunoblot are shown.
Fig. 8. Electron microscopic analysis of virion morphology. (A) wt infection, 37 1C. Ba
(D) vH4i,  ITPG. Bar¼200 nM. (E) vH4i,  ITPG. Bar¼200 nM. (F) Cts1, 37 1C. Bar¼30
virions were scored for quantiﬁcation: u¼undeﬁned, n¼nucleocapsid, f¼full, e¼em
sectioned in mutually perpendicular planes. Panel D contains three collapsed virions fpolymerase subunit, A24 (rpo132), are synthesized in normal
amounts and at normal times in a Cts1 infection as compared to a
wt infection. Most importantly, the levels of synthesis of these
proteins are not reduced in the Cts1 infection done under non-
permissive conditions, therefore the deﬁciencies of these proteins
observed in virions must represent a packaging defect. Interest-
ingly, the fact that H4 (rap94) is synthesized in normal amounts
in a Cts1 infection but not packaged suggests that the tempera-
ture sensitive mutation in Cts1 affects H4 interaction with either
the core RNA polymerase or VETF or both.
Electron microscopic analysis of mutant virions
To visualize in detail the internal structure of wt and mutant
virions, infected cells were prepared by high pressure freezing,
treated by freeze substitution followed by ultramicrotomy, and
examined by transmission electron microscopy as described in
the Materials and methods section. Representative images are
shown in Fig. 8. Based on experience evaluating numerous
samples, we developed a system for scoring individual virions.
Virions which showed evidence of an internal nucleocapsid
structure were identiﬁed as ‘‘nucleocapsid’’ (n). Virions in which
the internal regions of the core were of a normal size and whichr¼500 nM. (B) wt infection, 37 1C. Bar¼200 nM. (C) vH4i, þIPTG. Bar¼300 nM.
0 nM. (G) Cts1, 37 1C. Bar¼200 nM. Lettering in panels A, C, (E)–(G) shows how
pty, c¼collapsed. Panel B highlights two wt virions each with a nucleocapsid,
rom a vH4i infection,  IPTG.
Table 2
Wild type and mutant virion morphology.
Virus Particles counted Undeﬁned (%) Nucleocapsid (%) Full (%) Empty (%) Collapsed (%)
wt, 31 1C 457 173 (37.9) 19 (4.2) 262 (57.3) 3 (0.7) 0 (0.0)
Cts1, 31 1C 606 164 (27.1) 28 (4.6) 398 (65.7) 13 (2.2) 3 (0.5)
wt, 37 1C 766 201 (26.2) 114 (14.9) 395 (51.6) 56 (7.3) 0 (0.0)
Cts1, 37 1C 635 148 (23.3) 0 (0.0) 188 (29.6) 283 (44.6) 16 (2.5)
vH4i, þ IPTG 555 165 (29.7) 2 (0.4) 174 (31.4) 198 (35.7) 16 (2.9)
vH4i,  IPTG 479 96 (20.0) 1 (0.2) 121 (25.3) 247 (51.6) 14 (2.9)
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nucleocapsid were identiﬁed as ‘‘full’’ (f). Virions containing
lucent areas in the internal regions were labeled ‘‘empty’’ (e).
Virions in which the internal regions were both electron dense
and also apparently narrower than normal were labeled ‘‘col-
lapsed’’ (c). Structures which appeared to be virions but which
were sectioned in such a way as to prevent evaluation of the
internal structures were labeled as ‘‘undeﬁned’’. A quantitation of
these structures taken from several samples of wt and mutant
infections is shown in Table 2. In wt infected cells infected at
37 1C (Fig. 8A and B) or 31 1C (not shown), approximately 4–15%
of virions revealed evidence of a nucleocapsid, depending on the
particular preparation. Approximately 50–60% of virions in a wt
infection were identiﬁed as full. Relatively few wt virions
appeared empty (1–7%), and no collapsed virions were identiﬁed
in wt infections. Cells infected with Cts1 under permissive
conditions (31 1C) gave rise to a distribution of virion morphol-
ogies similar to wt infections. By contrast, in vH4i infections done
either in the presence (Fig. 8C) or absence (Fig. 8D and E) of IPTG
or in Cts1 infections done at a non-permissive temperature
(Fig. 8F and G), nucleocapsids were rare (o1%), full virions were
reduced in number, and numerous empty and collapsed virions
were identiﬁed. In summary, compared to wt infections, the H4
mutant virus infections resulted in formation of virions which
lack a nucleocapsid, and which also present aberrant morpholo-
gies identiﬁed here as empty or collapsed.Discussion
A review of the literature reveals that pox virions contain an
internal nucleocapsid (Peters and Mueller, 1963). This structure
has historically been difﬁcult to image, possibly because it is
degraded in the ﬁxation procedures most commonly used for
electron microscopy, and therefore the nucleocapsid has been
largely ignored for nearly 50 years. Recent advances in sample
preparation for electron microscopy, notably high pressure freez-
ing, result in better preservation of the nucleocapsid, facilitating
its characterization (Heuser, 2005; Sosinsky et al., 2008). We
hypothesize that the nucleocapsid contains viral DNA complexed
with transcription enzymes and perhaps other nucleocapsid-
speciﬁc structural proteins. Following on this hypothesis, we
reasoned that virions which do not encapsidate viral transcription
enzymes might contain aberrant nucleocapsid structures or lack
nucleocapsids altogether. The experiments presented here
demonstrate that virions which lack RNA polymerase and several
satellite RNA modiﬁcation enzymes do in fact lack nucleocapsids
and also display aberrant morphologies comprising virions which
are either ‘‘empty’’ or ‘‘collapsed’’ in appearance.
In our hands the techniques of high pressure freezing and
freeze substitution yield quantities of nucleocapsid-containing
virions that vary from preparation to preparation. This is evident
in Table 2, where two different wild type virus infections result in
4% and 15% nucleocapsid-containing virions. We have seen
preparations which contain up to 50% nucleocapsid-containingvirions (not shown). We suspect that the majority if not all
matured virions in the infected cell contain discrete nucleocapsid
structures, and we are investigating improvements to the tech-
nique that will reduce the preparation-speciﬁc variability. These
considerations suggest that nucleocapsids are still somewhat
labile using the current technology. This in turn raises the
possibility that H4 deﬁcient virus mutants are not in fact incap-
able of assembling a nucleocapsid, but rather that the nucleo-
capsid that is assembled in the absence of transcription
machinery is more labile that wt nucleocapsids and thus is
destroyed during sample preparation. Regardless of these caveats,
the data nevertheless shows a clear difference between wt and H4
mutant virions, demonstrating a clear correlation between the
presence of transcription machinery and the formation or stabi-
lity of the nucleocapsid.
Our characterization of the inducible H4 mutant, vH4i, repro-
duces precisely the original characterization by Zhang et al.
(1994). In particular, the mutant displays an intermediate
phenotype both in the presence and absence of inducer, reﬂected
in our studies by reduced infectivity of puriﬁed virions, a reduced
complement of selected virion transcription enzymes and
reduced core transcription in vitro. Zhang et al. (1994) did not
directly address the presence of the nucleocapsid in vH4i infec-
tions, however close inspection of their published electron micro-
graphs reveals virion morphologies consistent with the aberrant
morphologies observed here, in particular the presence of both
empty and collapsed virions. Consistent with the inducer-
independent intermediate phenotype of this mutant, we found
no detectable difference in virion morphology when vH4i infec-
tions done in the presence or absence of inducer were compared.
Speciﬁcally, nucleocapsid structures were absent and aberrant
morphologies comprising empty and collapsed virions were
observed under both conditions. As noted in the introduction,
vH4i was originally constructed in a fashion that deliberately
down-regulated H4 production even in the presence of inducer in
order to obtain a tight mutant with minimal H4 synthesis in the
absence of inducer. Growth of the mutant in the presence of
inducer provides for synthesis of H4 that is limited but never-
theless sufﬁcient to obtain a stock of virus suitable for analysis.
Given that in a wt infection the particle to infectivity ratio of
puriﬁed virus is approximately 30, it is not too surprising that the
growth advantage of vH4i in the presence of inducer is not clearly
reﬂected in the characteristics of puriﬁed or imaged virions.
The temperature sensitive mutant Cts1 recapitulates pre-
cisely the phenotype of vH4i, however this mutant displays a
clearer distinction between growth under permissive and non-
permissive conditions. Speciﬁcally, Cts1 virions grown at the
permissive temperature encapsidate a near normal complement
of transcription enzymes and possess a speciﬁc infectivity indis-
tinguishable from wt virus, and they are more active in core
transcription in vitro compared to Cts1 virions grown at the non-
permissive temperature. Cts1 virions grown at the permissive
temperature are nevertheless not completely normal since they
are reduced in in vitro core transcription activity compared to wt
virions. The proﬁle of encapsidated proteins in Cts1 virions
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proﬁle of vH4i virions produced under non-permissive conditions.
Speciﬁcally, Cts1 virions grown at 37 1C are deﬁcient in RNA
polymerase, capping enzyme, NPH I and the large poly(A)
polymerase subunit, while encapsidating normal amounts of the
small poly(A) polymerase subunit, the ssDNA binding protein (I3),
and two core proteins E8 and 4a. This result is consistent with the
model of Zhang et al. (1994) that the H4-VETF interaction recruits
viral RNA polymerase and associated RNA metabolism enzymes
to the virion. Most importantly for our purposes, Cts1 virions
produced under non-permissive lack nucleocapsids and present
aberrantly empty or collapsed virions indistinguishable from
virions produced during vH4i infections.
An interesting logical extension of the Zhang et al. (1994)
model for packaging of the transcription apparatus would be that
the viral DNA recruits RNA polymerase holoenzyme into imma-
ture virions in pre-initiation complexes positioned at each early
viral transcriptional promoter. Since the viral genome contains
approximately 100 early promoters (Yang et al., 2011), the model
therefore predicts that the virion should contain approximately
100 molecules of the RNA polymerase (including H4) and the viral
early transcription factor, VETF. Given the measured mass of the
vaccinia virion of 5 femtograms (Peng et al., 2006), one can use the
weight percent of each virion protein determined by mass spectro-
scopy (Chung et al., 2006) to calculate that mature virions contain
approximately 300 copies of RNA polymerase (including H4) and
240 copies of VETF, enticingly close to the predicted values.
The simplest interpretation of our results is that the viral RNA
polymerase and associated RNA metabolism enzymes are actually
a structural component of the virion nucleocapsid, so that when
these proteins are not encapsidated, the structure of the nucleo-
capsid is compromised. We cannot rule out that the RNA poly-
merase is normally localized to a virion compartment other than
the nucleocapsid and that the effects of the polymerase deﬁcit on
nucleocapsid structure are indirect, however this seems unlikely.
Several other vaccinia virus core protein mutants have been
characterized which under non-permissive conditions produce
particles that are non-infectious and/or are defective in virion
directed transcription but which nevertheless resemble mature
wt virions using conventional electron microscopic ﬁxation tech-
niques. These include a DNA topoisomerase (H6) (da Fonseca and
Moss, 2003), an RNA helicase (I8) (Gross and Shuman, 1996),
a protein phosphatase (H1) (Liu et al., 1995), and three core
proteins of unknown function: L4 (Wilcock and Smith, 1996), E8
(Boyd et al., 2010) and L3 (Resch and Moss, 2005). The DNA
topoisomerase and RNA helicase are obvious candidates for
components of the core transcription apparatus and as such could
be contained in the nucleocapsid. L4 is an abundant DNA binding
virion protein (VP8) and thus would be a prime candidate for a
major nucleocapsid structural protein. E8 and L3 are relatively
minor components of the core and would therefore be candidates
for minor structural proteins or enzymes required for core
transcription. The role of the H1 phosphatase in core structure
and transcription is unknown. Electron microscopic examination
of each of these mutants using high pressure freezing to max-
imize resolution may provide insights into the role of these
proteins in virion structure and function, in particular as it relates
to the nucleocapsid.Materials and methods
Cells and viruses
Viruses were grown in BSC-40 cells, an African green monkey
kidney cell line (Brockman and Nathans, 1974). Cells were culturedin Dulbecco’s Modiﬁed Eagle’s medium (Life Technologies, cat
12100-061) containing 10% fetal bovine serum, 0.12 mg/ml penicillin
(Sigma), 0.2 mg/ml streptomycin (Sigma) and 250 mg/l fungizone
(Sigma). The procedures for cell culture, virus infection, puriﬁcation,
plaque assay and one-step growth have been described previously
(Condit and Motyczka, 1981; Condit et al., 1983; Kato et al., 2004).
Wild-type vaccinia virus strain WR and the temperature sensitive
mutant virus Cts1 have been described (Condit and Motyczka, 1981;
Kane and Shuman, 1992). vH4i (Zhang et al., 1994) was obtained
from B. Moss (NIH). For permissive vH4i infections, IPTG was
included at a concentration of 5 mM.
Virus puriﬁcation
BSC40 cells were infected with either wt or mutant viruses at
moi¼5 at 31 1C or 37 1C either in the presence or absence of IPTG
as indicated. Cells were harvested when complete CPE was
observed, 48–71 h after infection depending on the incubation
temperature. Cell-associated virus was puriﬁed using a scaled
down version of the procedure detailed in Ausubel et al. (1994).
All steps were carried out at 4 1C in a buffer containing 10 mM
Tris HCl, pH 8.0. Six conﬂuent 150 mm dishes of infected BSC40
cells (1.8108 cells total) were used for each virus infection.
Infected cells were harvested by centrifugation, resuspended in
3 ml and Dounce homogenized. Nuclei were removed by centri-
fugation at 900 g for 10 min. The supernatant was saved and the
nuclei resuspended in 3 ml and re-extracted by Dounce homo-
genization. Nuclei were again removed by centrifugation and the
combined supernatants (6 ml) were layered on a 6 ml cushion of
36% sucrose and centrifuged in a Beckman SW41 rotor at
19,000 rpm for 80 min. The pellets were resuspended in 1 ml,
layered on a 10.5 ml, 24–40% sucrose gradient and centrifuged in
an SW41 rotor at 14,000 rpm for 40 min. The light scattering band
in the middle of the tube was collected in a volume not exceeding
4 ml, diluted to 12 ml and centrifuged in an SW41 rotor at
16,000 rpm for 60 min. Virus pellets were resuspended in 300 ml
and virus concentrations determined by measuring light scatter-
ing at OD260 (1 OD260¼1.21010 particles/ml).
Assay for virion DNA
Puriﬁed virus was serially diluted in a solution containing
0.4 N NaOH, 10 mM EDTA, incubated at 100 1C for 10 min, and
100 ml samples were applied to a nylon membrane pre-
equilibrated in 0.4 N NaOH using a slot blot apparatus (Schleicher
and Schuell). Wells were rinsed once with 0.4 N NaOH and
samples were neutralized by rinsing wells with once with 2 SSC.
The membrane was pre-hybridized in 6 SSC, 50% formamide, 0.5%
SDS, 5 Denhardt’s solution and 100 mg/ml ssDNA at 42 1C for 2 h,
then hybridized overnight in the same solution with a plasmid
containing the vaccinia virus Hind III E DNA fragment, randomly
32P-labeled using a DECAprime II kit (Life Technologies) according to
the manufacturer’s instructions. The membrane was washed 3 at
RT and 1 at 55 1C with 2 SSC, 0.1% SDS, and bound radioactivity
was measured using a phorphorimager.
Assay for virus core directed transcription in vitro
Permeabilized virion transcription reactions were done essen-
tially as described previously (Kato et al., 2004). 0.4 A260 nm
units of virus was incubated in a reaction mixture containing
60 mM Tris–HCl pH 8.0, 0.05% Nonidet P40 (NP40), 10 mM
dithiothreitol (DTT), 10 mM MgCl2, 5 mM ATP, 1 mM UTP,
1 mM GTP, 0.2 mM a-32P-CTP (100 mCi/mmol), at 31 1C. At var-
ious times 50-ml aliquots were removed, precipitated directly
with 5% TCA, ﬁltered onto a glass microﬁber ﬁlters (934-AH,
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tillation counting.
Immunoblots
For immunoblot analysis of virion proteins, puriﬁed virus was
boiled in SDS-gel sample buffer, proteins were separated by 11%
SDS-PAGE and transferred to nitrocellulose in 25 mM Tris–HCl,
192 mM glycine, 20% methanol at 4 1C overnight. The membrane
was blocked with a solution of TBS-T (50 mM Tris–HCl pH 7.5;
150 mM NaCl; 0.01% Tween 20) and 5% non-fat dry milk (TBS-TM)
for 1 h incubated with an appropriate dilution of the primary
antibody in TBS-TM overnight at 8 1C. The membrane was washed
5 times for 5 min with TBS-T and incubated with a horseradish-
conjugated secondary antibody (Santa Cruz Biotechnology)
diluted in TBS-TM for 2 h at 8 1C. The membrane was washed
5 times for 5 min and the protein complex detected by chemilu-
minescence (GE Healthcare). Sources and dilutions of antibodies
are as follows: E. Niles: D1 (1:2000), D11 (1:5000), D12 (1:6000),
E1 (1:1000), J3 (1:10,000); S. Shuman: A24 (1:5000); J6 (1:5000);
M. Esteban: A10 (1:2000); B. Moss: H4 (1:10,000); S. Broyles: E4
(1:1000); D. Evans: I3 (1:300). The anti E8 antibody has been
described (Kato et al., 2007) and was used at a 1:1000 dilution.
For immunoblot analysis of proteins made during infection,
conﬂuent monolayers of BSC40 cells in 60 mm dishes were
infected at moi¼10 with wt or Cts1 and incubated at various
temperatures as indicated. At various times, medium was
removed from the dishes, cells were washed with PBS and
200 ml of SDS sample buffer was added directly to the dish.
Samples were harvested and subjected to electrophoresis on an
11% SDS polyacrylamide gel and immunoblotted as described
above. Anti-H4 was used at a 1:10,000 dilution; anti-A24 was
used at a 1:5000 dilution.
Electron microscopy
BSC40 cells in 100 mm dishes were infected with Cts1, vH4i,
or wt virus at moi¼10 for 30 min. The inoculum was removed and
the cells incubated in serum-containing nutrient medium under
permissive (31 1C or þ IPTG) or non-permissive (37 1C or  IPTG)
conditions for 20 h. Monolayers were washed twice with versine,
treated with Accutase (Sigma) for 5 min to detach the cells and cells
were then resuspended in serum-containing DME. The cells were
pelleted by centrifugation, washed once with serum-free DME and
ﬁxed with 4% paraformaldehyde, 1% glutaraldehyde in cacodylate
buffer (0.1 M sodium cacodylate, 2 mM MgCL2, 1 mM CaCl2, 43 mM
NaCl pH 7.23) for 30 min on ice. Subsequent steps were carried out
at the University of Florida Interdisciplinary Center for Biotechnol-
ogy Research Electron Microscopy and BioImaging Laboratory.
Fixed cells were pelleted by gentle centrifugation, washed twice
with cacodylate buffer and resuspended with an equal volume
(50 ml) cryoprotectant, 20% [w/v] dextran (39,000 mol wt) prepared
in serum free DME. Dextran protected cell suspensions were loaded
into 6 mm aluminum Type A planchettes (Technotrade, Manchester,
NH), capped with Type B planchettes with their ﬂat side and loaded
into specimen carriers. This assembly was quickly loaded into a
holder and frozen instantaneously using a high pressure freezing
system (HPM 100, Leica Microsystems, Buffalo Grove, IL). After
freezing, the specimen carriers were submerged into LN2, and
planchettes containing cryo-ﬁxed cells were transferred to freeze
substitution media containing 1% osmium tetroxide, 0.1% (w/v)
uranyl acetate in dry acetone at 160 1C. Freeze substitution media
containing cell-planchettes were transferred to a temperature-
controlling device (EM AFSII, Leica Microsystems, Buffalo Grove, IL).
Freeze-substitution was performed with the following program,
90 1C for 86 h, slow warming up from 90 1C to 70 1C for16 h, from 70 1C to 45 1C for 12 h, from 45 1C to 20 1C for
2 h, from 20 1C to 4 1C for 2 h. After three acetone washes at 4 1C,
cells were removed from planchettes and handled at room tempera-
ture for resin embedding. Resin inﬁltration was carried out by
stepwise increase in concentrations of Spurrs resin (30%, 50%, 70%,
100%) using a Pelco BioWave laboratory microwave, ColdSpot and
EM Pro Vacuum chamber (Ted Pella, Redding, CA), with the setting of
20 Hg vacuum, 200W, 3 min. Specimens were polymerized in
standard curing oven at 60 1C for 2 day. Ultra-thin sections of
conventional trimmed resin blocks were collected on carbon-
Formvar copper 200mesh grids and post-stained 1 min with Rey-
nold’s lead citrate. Sections were examined with an H-7000 TEM
(Hitachi High Technologies America, Inc. Schaumburg, IL) operated at
100 kV and digital images acquired with a Veleta camera and iTEM
software (Olympus Soft-Imaging Solutions Corp, Lakewood, CO).Acknowledgments
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